Targeted Therapy
Precision cancer treatment that identifies and attacks the specific molecular features driving your tumour — offering effective disease control while limiting harm to healthy tissue.
- Biomarker-Guided Treatment Selection
- Monoclonal Antibody Therapy
- Tyrosine Kinase Inhibitors
- HER2 & Hormone Receptor-Targeted Therapy
- Combination & Sequential Regimens
Overview
Treating cancer at its molecular source
Targeted therapy represents a shift from treating cancer broadly to treating it precisely — identifying the specific genetic mutations, proteins, or pathways that allow a particular tumour to grow, and using drugs designed to block exactly that mechanism. Because these agents act on features specific to cancer cells, they can often achieve strong disease control with a different, and sometimes more manageable, side-effect profile than conventional chemotherapy.
Treatment begins with detailed biomarker and molecular testing of the tumour, identifying mutations or protein expressions such as HER2, EGFR, or hormone receptors that indicate which targeted agents are likely to be effective. Based on these results, a specific targeted drug or combination is selected — given alone, alongside chemotherapy, or in sequence with other treatments depending on the cancer type and stage. Throughout treatment, regular imaging and molecular reassessment track response, allowing the care team to adjust the regimen promptly if the cancer begins to develop resistance.
Because targeted therapy is often one part of a larger treatment plan, every case is discussed within a multidisciplinary tumour board — medical oncology, surgical oncology, and radiation oncology working together to sequence treatments for the best possible outcome.
What We Offer
Targeted Therapy Services
Precision treatments matched to the specific molecular profile of your cancer.
Biomarker & Molecular Testing
Genetic and molecular profiling of the tumour to identify specific mutations or markers that guide selection of the most effective targeted agent.
Monoclonal Antibody Therapy
Lab-engineered antibodies that identify and bind to specific proteins on cancer cells, blocking growth signals or marking cells for immune destruction.
Tyrosine Kinase Inhibitors
Oral targeted agents that block specific enzymes driving cancer cell growth and division, used for cancers with matching genetic mutations.
HER2-Targeted Therapy
Precision treatment for HER2-positive breast and other cancers, blocking the HER2 protein that drives tumour growth in these cases.
Anti-Angiogenic Therapy
Targeted agents that cut off the blood supply tumours need to grow, slowing progression and limiting spread.
Combination Targeted Regimens
Carefully sequenced combinations of targeted agents, or targeted therapy alongside chemotherapy, selected to maximise effectiveness for specific cancer profiles.
Response Monitoring & Protocol Adjustment
Regular imaging and molecular reassessment throughout treatment to confirm response and adjust therapy if resistance develops.
Targeted Therapy Education & Counselling
One-on-one sessions before starting treatment to explain the specific agent, expected side effects, and what to watch for — helping patients feel prepared at every step.
Vascular Access & Infusion Support
Placement and management of central venous access devices, along with comfortable, monitored infusion services for patients on extended targeted therapy regimens.
Our Approach
The Targeted Therapy Advantage
Precision treatment and protected quality of life, guided by your tumour’s biology.
A clear, supported path from first consultation through to long‑term follow‑up.
Treatment Guided by Tumour Biology
Drug selection is based on your tumour's specific molecular profile — not a standard regimen applied to every patient.
Close Monitoring Throughout Treatment
Regular imaging and molecular reassessment track response and detect resistance early, allowing prompt adjustments to your regimen.
Manageable Side-Effect Profile
Targeted agents act on specific cancer mechanisms, often allowing better preservation of daily function and quality of life during treatment.
Multidisciplinary, Whole-Person Care
Medical oncology, surgical oncology, and radiation oncology coordinate to sequence targeted therapy within your complete treatment plan.
Chemotherapy affects all rapidly dividing cells, while targeted therapy is designed to act specifically on molecular features present in cancer cells, often resulting in a different and sometimes more manageable side-effect profile.
Yes. Biomarker or molecular testing of the tumour is essential to determine whether targeted therapy is appropriate and which specific agent is likely to work for your cancer.
Both are used, depending on the specific drug. Some targeted agents are oral tablets taken at home, while others, such as monoclonal antibodies, are given by infusion.
Yes, in many cases targeted therapy is given alongside chemotherapy to improve effectiveness. Your oncologist will determine the right combination based on your cancer type.
Regular monitoring helps detect resistance early. If it develops, your treatment plan can be adjusted to a different targeted agent or an alternative approach.
Contact
Discuss Your Treatment Options
Every case is unique. Book a consultation to understand the safest and most personalised path forward for you.
Address
# 69, IOA Complex, Royapettah High Rd, Royapettah, Chennai, Tamil Nadu 600014
info@support.com
Our Number
+(0361) 234 567
